Condition: Helicobacter Pylori Infection · Sponsor: Sadat City University
This study intends to assess the possible effectiveness and safety of Diosmin and Hesperidin combination in patients with Helicobacter pylori Infection through evaluating its effect on stool antigen test and serum levels of inflammatory biomarkers as(TNF-A and MDA).
This description comes directly from the study's public registry record.
Aya Mosaad Swidan · 01208756300 · aya.swidan@fop.usc.edu.eg
Always discuss trial participation with your own doctor first.
| National Liver Institute | Shibīn al Kawm, Egypt | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06546111